FOR PHARMA TEAMS

Build conviction in the science behind every deal

Every stage of the deal, faster. Replace fragmented workflows with a single system that surfaces what matters earlier.

See Prudentia in actionSee Prudentia in action
  • SOC II aligned
A gloved researcher drawing medicine into a syringe from a vial, with rows of vials on a blue lab tray behind
DEALMAKING TODAY

Today’s fragmented approach can’t keep up

More assets to evaluate, more markets to source from. The same team, and the same tools that weren't built for this volume.

Without Prudentia

“We had 60 inbound programs last quarter. We moved 12 forward.”

WithPrudentia

“We screen everything. We make faster calls on what’s worth pursuing.”

Without Prudentia

“We liked the asset. We couldn’t build the internal case for the number.”

WithPrudentia

“Every position we took at the table had evidence behind it.”

Without Prudentia

“We found the risk in due diligence. Three months in.”

WithPrudentia

“We stop pursuing the wrong deals before they cost us.”

Deal flow

Manage your end-to-end deal pipeline

One system from sourcing to decision.

01Source

Centralize inbound and sourced opportunities across indications in one system.

02Screen

Screen every asset against consistent scientific and strategic criteria.

03Evaluate

Apply structured, evidence-based frameworks tailored to the asset's biology, modality, and stage.

04Diligence

Surface risks early and tie every conclusion directly to source evidence.

05Decide

Move to committee with a defensible valuation and the evidence behind it.

1 of 5
WHAT CHANGES WITH PRUDENTIA

Continuous drug assessment and deal diligence in a single platform

From early-stage programs to late-stage deals, evaluate every asset with a reproducible, evidence-based approach.

Screen opportunities with speed and consistency

01 •Prioritize programs for deeper evaluation across indications
02 •Screen assets using consistent scientific and strategic criteria
03 •Surface what will make or break the deal
04 •Centralize inbound and sourced opportunities in one system
Dashboard showing a biotech asset overview with key risks, evidence, and evaluation summary

Connect to all data in one place

01 •Connect to all internal and external data in one place
02 •Ingest data from VDRs, internal systems, and external datasets
03 •Integrate CRMs and core workflows
04 •Extend your existing data infrastructure and knowledge graph
Interface displaying integrated internal and external data sources in a unified evidence view

Scale dealmaking with faster, more rigorous scientific assessment

01 •Apply structured evaluation frameworks tailored to the asset’s biology, modality, and stage
02 •Leave no stone unturned with rigorous scientific assessment
03 •Continuously re-evaluate assets as new data and signals emerge
04 •Generate conclusions tied directly to source evidence
Scientific assessment interface analyzing asset biology, risk, and supporting evidence

Consider the full competitive landscape

01 •Contextualize the deal within the broader therapeutic and competitive landscape
02 •Identify differentiation and risks
03 •Continuously monitor real-time updates across the treatment landscape
04 •Inform deal positioning before first engagement
Competitive landscape view comparing assets across pipelines and emerging programs

Model valuations with confidence

01 •Translate technical assessment to deal valuation (licensing, M&A, deal structures)
02 •Model and stress-test alternative development strategies and scenarios
03 •Support portfolio prioritization, where to allocate capital
Valuation modeling interface showing scenario analysis and projected asset value

0% alignment with manual pharma diligence assessments

Extend your experts’ judgement - keeping them in the loop while surfacing signals earlier.

SECURITY

A trusted third party between buyer and seller

Life sciences dealmaking involves some of the most sensitive data in the industry. Prudentia operates as the connective intelligence layer between pharma, biotech, VDR, and deal team, with every role bounded and every handoff disclosed.

Visit our Trust CenterVisit our Trust Center
  • SOC II aligned
  • AWS-hosted

Secure Private Infrastructure

Single-tenant deployment with your data siloed and never shared across customers

Granular access controls

SSO integration with granular access controls and permissions

Data protected end-to-end

Encryption at rest and in transit, with complete audit trails

Built-in compliance

Your data is never used to train models, aligned with ISO/IEC 42001:2023